A detailed history of Claret Asset Management Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Claret Asset Management Corp holds 62,993 shares of JNJ stock, worth $9.1 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares
62,993
Previous 62,993 -0.0%
Holding current value
$9.1 Million
Previous $9.21 Million 10.88%
% of portfolio
1.67%
Previous 1.64%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $71,901 - $78,574
-498 Reduced 0.78%
62,993 $9.21 Million
Q1 2024

Apr 29, 2024

BUY
$155.22 - $162.74 $43,616 - $45,729
281 Added 0.44%
63,491 $10 Million
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $4,804 - $5,243
-33 Reduced 0.05%
63,210 $9.91 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $21,182 - $23,729
-136 Reduced 0.21%
63,243 $9.85 Million
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $150,336 - $161,791
-974 Reduced 1.51%
63,379 $10.5 Million
Q1 2023

Apr 18, 2023

SELL
$151.05 - $180.26 $45,617 - $54,438
-302 Reduced 0.47%
64,353 $9.98 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $24,350 - $27,328
-152 Reduced 0.23%
64,655 $11.4 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $102,121 - $113,636
-633 Reduced 0.97%
64,807 $10.6 Million
Q2 2022

Jul 28, 2022

SELL
$168.19 - $186.01 $88,804 - $98,213
-528 Reduced 0.8%
65,440 $11.6 Million
Q1 2022

Apr 04, 2022

BUY
$158.14 - $179.59 $33,367 - $37,893
211 Added 0.32%
65,968 $11.7 Million
Q4 2021

Feb 07, 2022

SELL
$155.93 - $173.01 $89,191 - $98,961
-572 Reduced 0.86%
65,757 $11.2 Million
Q3 2021

Dec 02, 2021

SELL
$161.5 - $179.47 $136,790 - $152,011
-847 Reduced 1.26%
66,329 $10.7 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $104,459 - $112,050
-655 Reduced 0.97%
67,176 $11.1 Million
Q1 2021

May 04, 2021

SELL
$153.07 - $170.48 $80,667 - $89,842
-527 Reduced 0.77%
67,831 $11.1 Million
Q4 2020

Feb 02, 2021

SELL
$137.11 - $157.38 $137,795 - $158,166
-1,005 Reduced 1.45%
68,358 $10.8 Million
Q3 2020

Oct 29, 2020

SELL
$140.38 - $153.83 $68,084 - $74,607
-485 Reduced 0.69%
69,363 $10.3 Million
Q2 2020

Aug 06, 2020

SELL
$128.81 - $155.51 $216,143 - $260,945
-1,678 Reduced 2.35%
69,848 $9.82 Million
Q1 2020

Apr 06, 2020

SELL
$111.14 - $153.99 $378,431 - $524,335
-3,405 Reduced 4.54%
71,526 $9.38 Million
Q4 2019

Jan 07, 2020

SELL
$127.5 - $146.44 $28,305 - $32,509
-222 Reduced 0.3%
74,931 $10.9 Million
Q3 2019

Oct 11, 2019

SELL
$126.95 - $142.14 $240,062 - $268,786
-1,891 Reduced 2.45%
75,153 $9.72 Million
Q2 2019

Jul 24, 2019

SELL
$131.15 - $144.24 $148,855 - $163,712
-1,135 Reduced 1.45%
77,044 $10.7 Million
Q1 2019

Apr 29, 2019

SELL
$125.72 - $139.79 $47,773 - $53,120
-380 Reduced 0.48%
78,179 $10.9 Million
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $322,455 - $388,080
-2,625 Reduced 3.23%
78,559 $10.1 Million
Q3 2018

Oct 30, 2018

BUY
$121.58 - $142.88 $93,738 - $110,160
771 Added 0.96%
81,184 $11.2 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $253,486 - $279,726
2,123 Added 2.71%
80,413 $9.76 Million
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $97,953 - $115,993
-783 Reduced 0.99%
78,290 $10 Million
Q4 2017

Mar 27, 2018

BUY
$131.22 - $143.62 $10.4 Million - $11.4 Million
79,073
79,073 $11 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.